Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

World Courier (UK) Ltd

World Courier is a provider of premium logistics services and the leading global specialty supplier of transportation, storage and distribution services for multinational biopharmaceutical clinical trials. Our service offerings include temperature-controlled and time-critical handling and transportation, temperature-controlled storage and distribution, specialized packaging, and customs brokerage services. Our services are utilized by over five hundred biopharmaceutical companies, including each of the top 50 global players, as well as all major Contract Research Organizations, Clinical Trial Suppliers and Central Labs.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

World Courier (UK) Ltd
8th Floor, Sea Containers House, 20 Upper Ground, London, SE1 9PD, United Kingdom
+44 (0)20 7928 7256
Contact World Courier (UK) Ltd
Website

 Latest Content from PMHub 

IBD Oxford MasterClass 2016 harnesses the chemistry between science and clinical practice

Press Releases | September 27, 2016 | Lucid Group Communications Limited

Leading Edge, part of the Lucid Group, delivered another successful Oxford MasterClass this year, which attracted over 260 delegates and 60 international inflammatory bowel disease (IBD) faculty, representing Europe, Asia, Australasia...

Artificial Intelligence: the new healthcare algorithm

White Papers and Resources | September 27, 2016 | Blue Latitude Health

The age of computers has hugely evolved, and with the emergence of effective machine learning, pattern recognition, and decision-making algorithms, Artificial Intelligence provides a revolutionary new approach to tailored healthcare....

Lucid Group becomes a sponsor of MedComms Networking

Press Releases | September 23, 2016 | Lucid Group Communications Limited

To help Lucid access the valuable medical communications professional network they have become a sponsor of MedComms Networking, headed by Peter Llewellyn. Jan Steele (Co-founder and COO of Lucid Group)...

Showcasing our multichannel capabilities in Berlin

White Papers and Resources | September 22, 2016 | Anthill Agency

Join Anthill for conferences in October to understand how to bring value to HCPs through multichannel communications

DAM and CMS: managing assets to maximise adoption and value

White Papers and Resources | September 19, 2016 | Blue Latitude Health

Senior Account Executive Dave Wood talks us through what DAM and CMS are, the role they play in the future of healthcare marketing, and how they can be best utilised...

Tenth Lucid Academy module delivered – nurturing talent and driving excellence

Press Releases | September 15, 2016 | Lucid Group Communications Limited

Celebrating the success of the Lucid Academy

Lucid launch new recruitment campaign to attract top talent in medical writing

Press Releases | September 8, 2016 | Lucid Group Communications Limited

We will offer talented writers an exclusive, tailor-made package to suit their individual needs and desires. We want you to define the framework of your Lucid Life contract – from...

Knowing your audience is key to successful medical education

Press Releases | September 7, 2016 | Lucid Group Communications Limited

Lucid Group understands that the goals of medical education are to disseminate best practice and advance patient outcomes. Our approach to meeting these goals centres on our appreciation of both...

How to enable each healthcare professional to fully understand your product

White Papers and Resources | September 7, 2016 | Anthill Agency

Read these three articles to understand how working at an individual level benefits all customers:

Alzheimer’s disease: reviewing the immediate treatment horizon

White Papers and Resources | September 1, 2016 | Blue Latitude Health

Account Manager Stuart Goodman takes a look at some of the promising categories of Phase 3 treatments that could soon be available to patients with Alzheimer's disease.